STOCKHOLDERS’ EQUITY |
9 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | NOTE 8 - STOCKHOLDERS’ EQUITY
As of June 30, 2026 the Company has 600,000,000 shares of commons stock authorized and 217,111,050 shares of common stock issued and outstanding, respectively.
During the nine months ended June 30, 2026, the Company issued 331,350 shares of common stock with a fair value of $165,041 for the acquisitions of DFLZ, HCL, and HSCL (see Note 6).
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|